𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial


Book ID
117310342
Publisher
The Lancet
Year
2012
Tongue
English
Weight
311 KB
Volume
379
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.